BIOMAT Database Logo BIOMAT Database Logo

The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion Group. 1997

H E Wilczek, and E Berglin, and I Blohmé, and L Bäckman, and I Fehrman, and R Källen, and G Nyberg, and J Säwe, and J Wahlberg
Dept of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D004304 Dosage Forms Completed forms of the pharmaceutical preparation in which prescribed doses of medication are included. They are designed to resist action by gastric fluids, prevent vomiting and nausea, reduce or alleviate the undesirable taste and smells associated with oral administration, achieve a high concentration of drug at target site, or produce a delayed or long-acting drug effect. Dosage Form,Form, Dosage,Forms, Dosage
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D013548 Sweden Country in northern Europe, bordering the Baltic Sea, between Finland and Norway. The capital is Stockholm.
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver
D016035 Pancreas Transplantation The transference of a pancreas from one human or animal to another. Grafting, Pancreas,Transplantation, Pancreas,Graftings, Pancreas,Pancreas Grafting,Pancreas Graftings,Pancreas Transplantations,Transplantations, Pancreas
D016041 Heart-Lung Transplantation The simultaneous, or near simultaneous, transference of heart and lungs from one human or animal to another. Grafting, Heart-Lung,Transplantation, Heart-Lung,Grafting, Heart Lung,Graftings, Heart-Lung,Heart Lung Transplantation,Heart-Lung Grafting,Heart-Lung Graftings,Heart-Lung Transplantations,Transplantation, Heart Lung,Transplantations, Heart-Lung

Related Publications

H E Wilczek, and E Berglin, and I Blohmé, and L Bäckman, and I Fehrman, and R Källen, and G Nyberg, and J Säwe, and J Wahlberg
Use of Sandimmun Neoral in renal transplant patients. International Sandimmun Neoral Study Group.
October 1994, Transplantation proceedings,
H E Wilczek, and E Berglin, and I Blohmé, and L Bäckman, and I Fehrman, and R Källen, and G Nyberg, and J Säwe, and J Wahlberg
Mass conversion from Sandimmun to Sandimmun Neoral: 1 1/2-year experience.
November 1997, Transplantation proceedings,
H E Wilczek, and E Berglin, and I Blohmé, and L Bäckman, and I Fehrman, and R Källen, and G Nyberg, and J Säwe, and J Wahlberg
Experience with clinical use of Sandimmun Neoral in renal transplant patients.
June 1996, Transplantation proceedings,
H E Wilczek, and E Berglin, and I Blohmé, and L Bäckman, and I Fehrman, and R Källen, and G Nyberg, and J Säwe, and J Wahlberg
Sandimmun-to-Neoral conversion in stable pediatric kidney transplant recipients.
August 1998, Transplantation proceedings,
H E Wilczek, and E Berglin, and I Blohmé, and L Bäckman, and I Fehrman, and R Källen, and G Nyberg, and J Säwe, and J Wahlberg
Clinical experience transferring kidney transplant patients from Sandimmun to Sandimmun Neoral--results after 3 months.
January 1995, Clinical nephrology,
H E Wilczek, and E Berglin, and I Blohmé, and L Bäckman, and I Fehrman, and R Källen, and G Nyberg, and J Säwe, and J Wahlberg
Sandimmun neoral pharmacokinetics: impact of the new oral formulation.
February 1995, Transplantation proceedings,
H E Wilczek, and E Berglin, and I Blohmé, and L Bäckman, and I Fehrman, and R Källen, and G Nyberg, and J Säwe, and J Wahlberg
Conversion from Sandimmun to Neoral in stable pediatric renal transplant recipients.
April 1998, Pediatric nephrology (Berlin, Germany),
H E Wilczek, and E Berglin, and I Blohmé, and L Bäckman, and I Fehrman, and R Källen, and G Nyberg, and J Säwe, and J Wahlberg
Clinical experience in transferring kidney transplant patients from sandimmun to sandimmun neoral--results after 6 months.
October 1995, Transplantation proceedings,
H E Wilczek, and E Berglin, and I Blohmé, and L Bäckman, and I Fehrman, and R Källen, and G Nyberg, and J Säwe, and J Wahlberg
A study to assess the efficacy, tolerability, and safety of a new oral formulation of Sandimmun--Sandimmun Neoral--in stable renal transplant patients.
December 1995, Transplantation proceedings,
H E Wilczek, and E Berglin, and I Blohmé, and L Bäckman, and I Fehrman, and R Källen, and G Nyberg, and J Säwe, and J Wahlberg
A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.
April 1995, Transplantation proceedings,
Copied contents to your clipboard!